Transamerica Financial Advisors Inc. Takes $58,000 Position in The Allstate Co. (NYSE:ALL)

Transamerica Financial Advisors Inc. purchased a new stake in The Allstate Co. (NYSE:ALL) in the 3rd quarter, according to its most recent disclosure with the SEC. The fund purchased 306 shares of the insurance provider’s stock, valued at approximately $58,000.

Several other hedge funds and other institutional investors have also modified their holdings of the business. Allspring Global Investments Holdings LLC boosted its holdings in shares of Allstate by 18.7% in the 3rd quarter. Allspring Global Investments Holdings LLC now owns 3,000,866 shares of the insurance provider’s stock valued at $569,114,000 after buying an additional 472,040 shares during the period. Raymond James & Associates boosted its stake in Allstate by 10.6% during the 3rd quarter. Raymond James & Associates now owns 1,517,800 shares of the insurance provider’s stock valued at $287,851,000 after purchasing an additional 145,986 shares during the period. Dimensional Fund Advisors LP boosted its stake in Allstate by 3.4% during the 2nd quarter. Dimensional Fund Advisors LP now owns 1,437,688 shares of the insurance provider’s stock valued at $229,545,000 after purchasing an additional 47,038 shares during the period. Pathway Financial Advisers LLC boosted its stake in Allstate by 18,472.5% during the 3rd quarter. Pathway Financial Advisers LLC now owns 1,052,687 shares of the insurance provider’s stock valued at $199,642,000 after purchasing an additional 1,047,019 shares during the period. Finally, Hsbc Holdings PLC boosted its stake in Allstate by 3.3% during the 2nd quarter. Hsbc Holdings PLC now owns 1,007,953 shares of the insurance provider’s stock valued at $160,948,000 after purchasing an additional 31,789 shares during the period. 76.47% of the stock is owned by institutional investors and hedge funds.

Insider Buying and Selling

In other news, insider John E. Dugenske sold 36,367 shares of the business’s stock in a transaction that occurred on Friday, September 20th. The shares were sold at an average price of $191.38, for a total transaction of $6,959,916.46. Following the sale, the insider now owns 27,364 shares in the company, valued at $5,236,922.32. The trade was a 57.06 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Insiders own 1.80% of the company’s stock.

Allstate Stock Up 0.2 %

NYSE ALL opened at $208.19 on Thursday. The company has a debt-to-equity ratio of 0.43, a current ratio of 0.40 and a quick ratio of 0.40. The company’s 50 day simple moving average is $192.34 and its 200 day simple moving average is $178.57. The Allstate Co. has a 12 month low of $134.17 and a 12 month high of $209.88. The company has a market capitalization of $55.13 billion, a P/E ratio of 13.48, a PEG ratio of 1.80 and a beta of 0.48.

Allstate (NYSE:ALL) last released its earnings results on Wednesday, October 30th. The insurance provider reported $3.91 EPS for the quarter, topping analysts’ consensus estimates of $2.20 by $1.71. Allstate had a net margin of 6.77% and a return on equity of 26.67%. The business had revenue of $16.63 billion for the quarter, compared to the consensus estimate of $14.57 billion. During the same period in the previous year, the firm earned $0.81 EPS. The business’s revenue for the quarter was up 14.7% on a year-over-year basis. Equities research analysts expect that The Allstate Co. will post 16.07 earnings per share for the current fiscal year.

Allstate Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Thursday, January 2nd. Investors of record on Friday, November 29th will be issued a $0.92 dividend. The ex-dividend date of this dividend is Friday, November 29th. This represents a $3.68 dividend on an annualized basis and a dividend yield of 1.77%. Allstate’s payout ratio is currently 23.83%.

Analysts Set New Price Targets

ALL has been the subject of a number of analyst reports. Roth Mkm reissued a “buy” rating and set a $200.00 target price on shares of Allstate in a research note on Wednesday, August 14th. TD Cowen boosted their target price on shares of Allstate from $193.00 to $224.00 and gave the company a “buy” rating in a research note on Tuesday, September 3rd. UBS Group boosted their target price on shares of Allstate from $216.00 to $225.00 and gave the company a “buy” rating in a research note on Monday, November 4th. Wells Fargo & Company boosted their target price on shares of Allstate from $175.00 to $186.00 and gave the company an “equal weight” rating in a research note on Tuesday, November 5th. Finally, Bank of America boosted their target price on shares of Allstate from $216.00 to $233.00 and gave the company a “buy” rating in a research note on Friday, October 18th. One investment analyst has rated the stock with a sell rating, two have assigned a hold rating, thirteen have issued a buy rating and one has assigned a strong buy rating to the company. Based on data from MarketBeat, Allstate currently has an average rating of “Moderate Buy” and a consensus price target of $217.19.

Allstate Profile

The Allstate Corporation, together with its subsidiaries, provides property and casualty, and other insurance products in the United States and Canada. It operates in five segments: Allstate Protection; Protection Services; Allstate Health and Benefits; Run-off Property-Liability; and Corporate and Other segments.